BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2025 8:12:13 AM | Browse: 217 | Download: 702
 |
Received |
|
2024-08-31 07:10 |
|
Peer-Review Started |
|
2024-08-31 07:10 |
|
First Decision by Editorial Office Director |
|
2024-10-23 01:57 |
|
Return for Revision |
|
2024-10-23 01:57 |
|
Revised |
|
2024-10-30 14:12 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-12-02 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-02 08:21 |
|
Articles in Press |
|
2024-12-02 08:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-12-17 07:24 |
|
Publish the Manuscript Online |
|
2025-01-18 08:12 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Case Report |
| Article Title |
Anti-programmed death-1 immunotherapy-promising treatment for metastatic colorectal cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tian-Hao Guo, Sheng-Wei Hong, Wen-Jian Zhu, Yi-Fan Hui, Wen-Li Qiu, Yan Wu, Xuan Li, Fei Ke, Liu Li and Hai-Bo Cheng |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Key R and D Program of China |
No. 2022YFC3500200 |
| National Key R and D Program of China |
No. 2022YFC3500204 |
| Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine |
No. ZYYCXTD-C-202208 |
| NATCM’s Project of High-level Construction of Key TCM Disciplines |
No. [2023]85 |
| Qing Lan Project of Jiangsu Higher Education Institutions |
No. [2023]27 |
| Jiangsu Postgraduate Practice Innovation Plan |
No. SJCX22_0706 |
| General project of Universities’ philosophy and social science in Jiangsu Province |
No. 2024SJYB0564 |
|
| Corresponding Author |
Hai-Bo Cheng, Chief Physician, PhD, Professor, The First Clinical Medical College, Nanjing University of Chinese Medicine, No. 138 Xianlin Road, Nanjing 210023, Jiangsu Province, China. haibocheng@njucm.edu.cn |
| Key Words |
Colorectal cancer; Colorectal liver metastasis; Drug resistance; Immunotherapy; Anti-programmed death-1; Case report |
| Core Tip |
The patient described in this report has survived for more than 6 years since the diagnosis of colorectal liver metastasis. The patient achieved clinical remission after anti-programmed death-1 (PD-1) immunotherapy when different systemic therapies failed. This case demonstrates the promising potential of holistic integrative medicine, combining anti-PD-1 immunotherapy with complementary and alternative treatments, for managing advanced malignancies amid drug resistance and disease progression. |
| Publish Date |
2025-01-18 08:12 |
| Citation |
Guo TH, Hong SW, Zhu WJ, Hui YF, Qiu WL, Wu Y, Li X, Ke F, Li L, Cheng HB. Anti-programmed death-1 immunotherapy-promising treatment for metastatic colorectal cancer: A case report. World J Gastrointest Oncol 2025; 17(2): 100954 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i2/100954.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i2.100954 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
